Gregoire Justeau

Angers, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Treatment patterns and outcomes in advanced and metastatic lung cancer in France: Results from the Epidemiological Strategy and medical Economics (ESME) database lung cancer in France.

Treatment patterns and outcomes in advanced and metastatic lung cancer in France: Results from the Epidemiological Strategy and medical Economics (ESME) database lung cancer in France.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: June 16, 2026

Female pulmonologists experienced poorer health and reduced quality of life related to their professional activities.

Female pulmonologists experienced poorer health and reduced quality of life related to their professional activities.

Journal: ERJ open research

Published: October 10, 2025

Association of sleep-related hypoxemia with survival in patients with non-small cell lung cancer - the NEOSAS-GFPC study group.

Association of sleep-related hypoxemia with survival in patients with non-small cell lung cancer - the NEOSAS-GFPC study group.

Journal: Chest

Published: June 12, 2025

Efficacy of first-line treatments for advanced pulmonary sarcomatoid carcinomas: a real-world analysis.

Efficacy of first-line treatments for advanced pulmonary sarcomatoid carcinomas: a real-world analysis.

Journal: ESMO open

Published: February 10, 2025

Prediction of survival and outcomes with depth of response at 6 months in metastatic non-small-cell lung cancer patients treated with chemotherapy and immunotherapy combination: SPORE trial.

Prediction of survival and outcomes with depth of response at 6 months in metastatic non-small-cell lung cancer patients treated with chemotherapy and immunotherapy combination: SPORE trial.

Journal: ESMO open

Published: February 04, 2025

Clinical characteristics and management of long survivors in extensive stage small cell lung cancer.

Clinical characteristics and management of long survivors in extensive stage small cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: December 28, 2024

SREBP-mediated Signaling Restores Stem Cell Niche Properties in Human Lung Fibroblasts.

SREBP-mediated Signaling Restores Stem Cell Niche Properties in Human Lung Fibroblasts.

Journal: American journal of respiratory cell and molecular biology

Published: November 18, 2024

First-Line Pembrolizumab Efficacy in Octogenarians With NSCLCs Expressing ≥ 50% PD-L1 (ESCKEYP GFPC 05-2018).

First-Line Pembrolizumab Efficacy in Octogenarians With NSCLCs Expressing ≥ 50% PD-L1 (ESCKEYP GFPC 05-2018).

Journal: Clinical lung cancer

Published: November 17, 2024

Real-world treatment and retreatment patterns and outcomes in patients with advanced or metastatic non-small cell lung cancer following nivolumab monotherapy in second line or later in France: an I-O Optimise analysis.

Real-world treatment and retreatment patterns and outcomes in patients with advanced or metastatic non-small cell lung cancer following nivolumab monotherapy in second line or later in France: an I-O Optimise analysis.

Journal: Frontiers in oncology

Published: November 12, 2024

Safety and Patient-Reported outcomes of atezolizumab plus chemotherapy with or without bevacizumab in stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies (GFPC 06-2018 study).

Safety and Patient-Reported outcomes of atezolizumab plus chemotherapy with or without bevacizumab in stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies (GFPC 06-2018 study).

Journal: Lung cancer (Amsterdam, Netherlands)

Published: April 20, 2024

A prospective analysis of the management practices for patients with Stage-III-N2Non-Small-Cell lung cancer (OBSERVE IIIA-B GFPC 04-2020Study).

A prospective analysis of the management practices for patients with Stage-III-N2Non-Small-Cell lung cancer (OBSERVE IIIA-B GFPC 04-2020Study).

Journal: Lung cancer (Amsterdam, Netherlands)

Published: March 05, 2024

Clinical characteristic and survival outcomes of patients with advanced NSCLC according to KRAS mutational status in the French real-life ESME cohort.

Clinical characteristic and survival outcomes of patients with advanced NSCLC according to KRAS mutational status in the French real-life ESME cohort.

Journal: ESMO open

Published: February 10, 2024

Showing 1-12 of 32

Last Updated: 09/26/2026